Skip to main content
. Author manuscript; available in PMC: 2015 May 19.
Published in final edited form as: J Control Release. 2013 Jun 2;170(2):219–225. doi: 10.1016/j.jconrel.2013.05.023

Fig. 5.

Fig. 5

Pharmacokinetics of the sfGFP-WT and the sfGFP-Pal. Four mice were intravenously administered the sfGFP-Pal (square) or the sfGFP-WT (triangle), respectively, and serum concentrations were measured by ELISA at different time points (mean ± s.d.): 0 (10 min), 3, and 6 h for the sfGFP-WT; 0 (10 min), 3, 6, 24, and 30 h for the sfGFP-Pal. Data were normalized with regard to the initial value, plotted in a logarithmic scale versus time post-injection, and fitted into a straight line (R2 = 0.98 for the sfGFP-WT and 0.97 for the sfGFP-Pal).